Emerging novel methodologies to understand and strategically target long-lived plasma cells in vaccine design to induce durable immunity.
Saved in:
| Title: | Emerging novel methodologies to understand and strategically target long-lived plasma cells in vaccine design to induce durable immunity. |
|---|---|
| Authors: | Cusimano G; Merck & Co., Inc., Infectious Diseases and Vaccines, Rahway, NJ, United States., Staupe RP; Merck & Co., Inc., Infectious Diseases and Vaccines, Rahway, NJ, United States., Sullivan NL; Merck & Co., Inc., Infectious Diseases and Vaccines, Rahway, NJ, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Feb 06; Vol. 16, pp. 1680375. Date of Electronic Publication: 2026 Feb 06 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41726181 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Emerging novel methodologies to understand and strategically target long-lived plasma cells in vaccine design to induce durable immunity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cusimano+G%22">Cusimano G</searchLink>; Merck & Co., Inc., Infectious Diseases and Vaccines, Rahway, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Staupe+RP%22">Staupe RP</searchLink>; Merck & Co., Inc., Infectious Diseases and Vaccines, Rahway, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Sullivan+NL%22">Sullivan NL</searchLink>; Merck & Co., Inc., Infectious Diseases and Vaccines, Rahway, NJ, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Feb 06; Vol. 16, pp. 1680375. <i>Date of Electronic Publication: </i>2026 Feb 06 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41726181 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2025.1680375 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1680375 Titles: – TitleFull: Emerging novel methodologies to understand and strategically target long-lived plasma cells in vaccine design to induce durable immunity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cusimano G – PersonEntity: Name: NameFull: Staupe RP – PersonEntity: Name: NameFull: Sullivan NL IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 02 Text: 2026 Feb 06 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
